Quantification of functionalised gold nanoparticle-targeted knockdown of gene expression in HeLa cells

PLoS ONE

Volumn 9, Issue 6, 2014, Pages

  Jiwaji, Meesbah ^a,e   Sandison, Mairi E ^a   Reboud, Julien ^a   Stevenson, Ross ^b   Daly, Rónán ^a   Barkess, Gráinne ^a   Faulds, Karen ^b   Kolch, Walter ^a,c   Graham, Duncan ^b   Girolami, Mark A ^a,d   Cooper, Jonathan M ^a   Pitt, Andrew R ^a,e  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b UNIVERSITY OF STRATHCLYDE   (United Kingdom)

^c UNIVERSITY COLLEGE DUBLIN   (Ireland)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

^e ASTON UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GOLD NANOPARTICLE; MESSENGER RNA; METALLOTHIONEIN II; OLIGONUCLEOTIDE; SINGLE STRANDED DNA; SINGLE STRANDED RNA; SMALL INTERFERING RNA; ANTISENSE OLIGONUCLEOTIDE; GOLD; METAL NANOPARTICLE; METALLOTHIONEIN; MT2A PROTEIN, HUMAN;

ARTICLE; AUTOPHAGOSOME; CELLULAR DISTRIBUTION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DNA SEQUENCE; FLUORESCENCE MICROSCOPY; GENE EXPRESSION; GENE SILENCING; GENE TARGETING; GENETIC TRANSCRIPTION; HELA CELL LINE; HUMAN; HUMAN CELL; POLYMERASE CHAIN REACTION; PROTEIN TARGETING; RNA SEQUENCE; WESTERN BLOTTING; CHEMISTRY; GENETIC TRANSFECTION; GENETICS; METABOLISM; PROCEDURES; ULTRASTRUCTURE;

DNA, SINGLE-STRANDED; GENE KNOCKDOWN TECHNIQUES; GOLD; HELA CELLS; HUMANS; METAL NANOPARTICLES; METALLOTHIONEIN; OLIGONUCLEOTIDES, ANTISENSE; RNA, MESSENGER; RNA, SMALL INTERFERING; TRANSFECTION;

EID: 84903197181     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0099458     Document Type: Article

References (64)

1. McCormick F (2001) Cancer gene therapy: fringe or cutting edge? Nat Rev Cancer 1: 130-141.
2. Opalinska JB, Gewirtz AM (2002) Nucleic-acid therapeutics: basic principles and recent applications. Nat Rev Drug Discovery 1: 503-514. (Pubitemid 37361504)
3. Kim JH, Jang HH, Ryou SM, Kim S, Bae J et al. (2010) A functionalized gold nanoparticles-assisted universal carrier for antisense DNA. Chem Commun 46: 4151-4153.
4. Kay MA, Glorioso JC, Naldini L (2001) Viral vectors for gene therapy: the art of turning infectious agents into vehicles of therapeutics. Nat Med 7: 33-40. (Pubitemid 32095639)
5. Raper SE, Chirmule N, Lee FS, Wivel NA, Bagg S, et al. (2003) Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer. Mol Genet Metab 80: 148-158. (Pubitemid 37272241)
6. Hacein-Bey-Abina S, von Kalle C, Schmidt M, Le Deist F, Wulffraat N, et al. (2003) A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency. N Engl J Med 348: 255-256. (Pubitemid 36077924)
7. Verma IM, Somia N (1997) Gene therapy - promises, problems and prospects. Nature 389: 239-242. (Pubitemid 27406627)
8. Green JJ, Langer R, Anderson DG (2008) A Combinatorial Polymer Library Approach Yields Insight into Nonviral Gene Delivery. Acc Chem Res 41: 749-759.
9. Mintzer MA, Simanek EE (2009) Nonviral Vectors for Gene Delivery. Chem Rev 109: 259-302.
10. Guo X, Szoka Jr FC (2003) Chemical Approaches to Triggerable Lipid Vesicles for Drug and Gene Delivery. Acc Chem Res 36: 335-341.
11. Tekade RK, Kumar PV, Jain NK (2009) Dendrimers in Oncology: An Expanding Horizon. Chem Rev 109: 49-87.
12. Soppimath KS, Aminabhavi TM, Kulkarni AE, Rudzinski WE (2001) Biodegradable polymeric nanoparticles as drug delivery devices. J Controlled Release 70: 1-20. (Pubitemid 32144788)
13. Kocbek P, Obermajer N, Cegnar M, Kos J, Kristl J (2007) Targeting cancer cells using PLGA nanoparticles surface modified with monoclonal antibody. Journal of Controlled Release 120: 18-26. (Pubitemid 46874614)
14. Van de Broek B, Devoogdt N, D'Hollander A, Gijs HL, Jans K, et al. (2011) Specific cell targeting with nanobody conjugated branched gold nanoparticles for photothermal therapy. ACS Nano 5: 4319-4328.
15. Prato M, Kostarelos K, Bianco A (2008) Functionalized Carbon Nanotubes in Drug Design and Discovery. Acc Chem Res 41: 60-68.
16. Cheon J, Lee JH (2008) Synergistically Integrated Nanoparticles as Multimodal Probes for Nanobiotechnology. Acc Chem Res 41: 1630-1640.
17. Trewyn BG, Slowing II, Giri S, Chen HT, Lin VSY (2007) Synthesis and Functionalization of a Mesoporous Silica Nanoparticle Based on the Sol-Gel Process and Applications in Controlled Release. Acc Chem Res 40: 846-853.
18. Slowing II, Vivero-Escoto JL, Wu CW, Lin VSY (2008) Mesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriers. Adv Drug Delivery Rev 60: 1278-1288.
19. Murphy CJ, Gole AM, Stone JW, Sisco PN, Alkilany AM et al. (2008) Gold Nanoparticles in Biology: Beyond Toxicity to Cellular Imaging. Acc Chem Res 41: 1721-1730.
20. Chen PC, Mwakwari SC, Oyelere AK (2008) Gold nanoparticles: From nanomedicine to nanosensing. Nanotechnology Science and Applications 1: 45-66.
21. Daniel MC, Astruc D (2004) Gold Nanoparticles: Assembly, Supramolecular Chemistry, Quantum-Size-Related Properties, and Applications toward Biology, Catalysis, and Nanotechnology. Chem Rev 104: 293-346.
22. Connor EE, Mwamuka J, Gole A, Murphy CJ, Wyatt MD (2005): Gold Nanoparticles Are Taken Up by Human Cells but Do Not Cause Acute Cytotoxicity. Small 1: 325-327. (Pubitemid 43951781)
23. Patra HK, Banerjee S, Chaudhuri U, Lahiri P, Dasgupta AK (2007) Cell selective response to gold nanoparticles. Nanomedicine: Nanotechnology, Biology, and Medicine 3: 111-119. (Pubitemid 46899618)
24. Gu YJ, Cheng J, Lin CC, Lam YW, Cheng SH et al. (2009) Nuclear penetration of surface functionalized gold nanoparticles. Toxicology and Applied Pharmacology 237: 196-204.
25. Sandhu KK, Mclntosh CM, Simard JM, Smith SW, Rotello VM (2002) Gold Nanoparticle-Mediated Transfection of Mammalian Cells. Bioconjugate Chem 13: 3-6. (Pubitemid 34119628)
26. Ghosh PS, Kim CK, Han G, Forbes NS, Rotello VM (2008) Efficient Gene Delivery Vectors by Tuning the Surface Charge Density of Amino Acid-Functionalized Gold Nanoparticles. ACS Nano 2: 2213-2218.
27. Agbasi-Porter C, Ryman-Rasmussen J, Franzen S, Feldheim D (2006) Transcription Inhibition Using Oligonucleotide-Modified Gold Nanoparticles. Bioconjugate Chem 17: 1178-1183. (Pubitemid 44455325)
28. Tsai CY, Shiau AL, Cheng PC, Shieh DB, Chen DH et al. (2004) A Biological Strategy for Fabrication of Au/EGFP Nanoparticle Conjugates Retaining Bioactivity. Nano Lett 4: 1209-1212.
29. Rosi NL, Giljohann DA, Thaxton CS, Lytton-Jean AKR, Han MS et al. (2006) Oligonucleotide-Modified Gold Nanoparticles for Intracellular Gene Regulation. Science 312: 1027-1030.
30. Taylor U, Klein S, Petersen S, Kues W, Barcikowski S et al. (2010) Nonendosomal Cellular Uptake of Ligand-Free, Positively Charged Gold Nanoparticles. Cytometry Part A 77: 439-446.
31. Zhang S, Li J, Lykotrafitis G, Bao G, Suresh S (2009) Size-Dependent Endocytosis of Nanoparticles. Adv Mater 21: 419-424.
32. Maxfield FR, McGraw TE (2004) Endocytic recycling. Nature Reviews 4: 121-132. (Pubitemid 38160255)
33. Watson P, Jones AT, Stephens DJ (2005) Intracellular trafficking pathways and drug delivery: fluorescence imaging of living and fixed cells. Advanced Drug Delivery Reviews 57: 43-61. (Pubitemid 39424063)
34. Kagi JHR, Kojima Y (1987) Chemistry and biochemistry of metallothionein. In: Kagi JHR, Kojima Y (eds.), Metallothionein II, pp. 25-61. Birkhauser Verlag, Basel.
35. Leyshon-Sorland K, Morkrid L, Rugstad HE (1993) Metallothionein: a protein conferring resistance in vitro to tumor necrosis factor. Cancer Res 53: 4874-4880. (Pubitemid 23326181)
36. Krizkova S, Fabrik I, Adam V, Hrabeta J, Eckschlager T et al. (2009) Metallothionein - a promising tool for cancer diagnostics. Bratislava Medical Journal, 110: 93-97.
37. Nordberg M (1998) Metallothioneins: historical review and state of knowledge. Talanta, 46: 243-254.
38. Koizumi S, Suzuki K, Ogra Y, Yamada H, Otsuka F (1999) Transcriptional activity and regulatory protein binding of metal-responsive elements of the human metallothionein-IIA gene. European Journal of Biochemistry 259: 635-642. (Pubitemid 29075489)
39. Karin M, Haslinger A, Heguy A, Dietlin T, Cooke T (1987) Metal responsive elements act as positive modulators of human metallothionein-IIA enhancer activity. Mol Cell Biol 7: 606-613. (Pubitemid 17004523)
40. Skroch P, Buchman C, Karin M (1993) Regulation of human and yeast metallothionein gene transcription by heavy metal ions. Prog Clin Biol Res 380: 113-128.
41. Turkevich J, Stevenson PC, Hillier J (1951) A study of the nucleation and growth processes in the synthesis of colloidal gold. Discuss Faraday Soc 11: 55-75.
42. Jiwaji M, Daly R, Pansare K, McMcLean P, Yang J et al. (2010) The Renilla luciferase gene as a reference gene for normalization of gene expression in transiently transfected cells. BMC Mol Biol 11: 103.
43. Plummer M (2003) JAGS:A program for analysis of Bayesian graphical models using Gibbs sampling. Proceedings of the 3rd International Workshop on Distributed Statistical Computing.
44. Plummer M, Best N, Cowles K, Vines K (2006) CODA: Convergence Diagnosis and Output Analysis for MCMC. R News 6: 11-17.
45. Vijayakumar S, Ganesan S (2013) In Vitro Cytotoxicity Assay on Gold Nanoparticles with Different Stabilizing Agents. Journal of Nanomaterials doi:10.1155/2012/734398.
46. Wang SH, Lee CW, Chiou A, Wei PK (2010) Size-dependent endocytosis of gold nanoparticles studied by three-dimensional mapping of plasmonic scattering images. Journal of Nanobiotechnology 8: 33.
47. Brust M, Fink J, Bethell D, Schiffrin D (1995) Synthesis and reactions of functionalised gold nanoparticles. Journal of the Chemical Society: Chemical Communications 1995: 1655-1656.
48. CORE = 1.5 nm) Phosphine-stabilized Nanoparticles. Journal of the American Chemical Society 122: 12890-12891.
49. Daniel MC, Astruc D (2004) Gold nanoparticles: assembly, supramolecular chemistry, quantum-size-related properties, and applications toward biology, catalysis, and nanotechnology. Chemical Reviews 104: 293-346.
50. Haes AJ, Hall WP, Chang L, Klein WL, Van Duyne RP (2004) A localized surface plasmon resonance biosensor: first steps toward an assay for Alzheimer's disease. Nano Letters 4: 1029-1034. (Pubitemid 38859975)
51. Templeton AC, Wuelfing WP, Murray RW (1999) Monolayer-Protected Cluster Molecules. Accounts of Chemical Research 33: 27-36.
52. Bonnemann H, Richards R (2001) Nanoscopic Metal Particles 2 Synthetic Methods and Potential Applications. European Journal of Inorganic Chemistry 10: 2455-2480. (Pubitemid 32943557)
53. Haes AJ, Zhao J, Zou S, Own CS, Marks LD et al. (2005) Solution-Phase, Triangular Ag Nanotriangles Fabricated by Nanosphere Lithography. Journal of Physical Chemistry B, 109: 11158-11162. (Pubitemid 40858006)
54. Ulman A (1996) Formation and Structure of Self-Assembled Monolayers. Chemical Reviews 96: 1533-1554.
55. McKenzie F, Steven V, Ingram A, Graham D (2009) Quantitation of biomolecules conjugated to nanoparticles by enzyme hydrolysis. Chem Commun 20: 2872-2874.
56. www.malvern.co.uk, Zetasizer Nano series technical note MRK654-01.
57. J. Wrzesien J, Graham D (2012) Synthesis of SERS active nanoparticles for detection of biomolecules. Tetrahedron 68: 1230-1240.
58. Paddison PJ, Caudy AA, Hannon GJ (2002) Stable suppression of gene expression by RNAi in mammalian cells. PNAS 99: 1443-1448. (Pubitemid 34136512)
59. Bonetta L (2004) RNAi: Silencing never sounded better. Nature Methods 1: 79-86.
60. Kim DH, Rossi J (2008) RNAi mechanisms and applications. Biotechniques 44: 613-616. (Pubitemid 351656279)
61. Kershaw WC, Klaassen CD (1992) Degradation and Metal Composition of Hepatic lsometallothioneins in Rats. Toxicology and Applied Pharmacology 112: 24-31.
62. Kim EY, Stanton J, Vega RA, Kunstman KJ, Mirkin CA et al. (2006) A real-time PCR-based method for determining the surface coverage of thiol-capped oligonucleotides bound onto gold nanoparticles Nucleic Acids Research 34:7 doi:10.1093/nar/gkl147.
63. Masters JR (2002) HeLa cells 50 years on: the good, the bad and the ugly. Nat Rev Cancer 2: 315-319.
64. Karin M, Haslinger A, Holtgreve H, Cathala G, Slater E et al. (1984) Activation of a heterologous promoter in response to dexamethasone and cadmium by metallothionein gene 5′-flanking DNA. Cell 36: 371-379. (Pubitemid 14126228)